French Competition Authority announces healthcare sector enquiry during presentation of 2016 Annual Report

Patricia Carmona Botana

The President of the French Competition Authority (FCA), Isabelle de Silva, recently confirmed in a radio interview the forthcoming launch of a sector-wide enquiry into the healthcare sector, with a special focus on hospital procurement, biomedical laboratories and pharmacies.  The enquiry aims to address the major economic and financial challenges that the sector entails for the Read More

Excessive pricing of medicines and antitrust: not a great week for Aspen

Emilio De Giorgi

This week Aspen received two pieces of bad news. On 13 June, the South African Competition Commission (SACC) announced the opening of an investigation against Aspen for its suspected excessive prices in the provision of certain cancer medicinal products (Leukeran, Alkeran and Myleran). The following day, the Italian administrative court of Lazio rejected the appeal Read More

DG COMP 2016 Report on Competition Policy: overview on the Life Sciences sector

Patricia Carmona Botana

On 31 May, the European Commission published its 2016 Report on Competition Policy. The Report, which is composed of a Communication and a detailed Staff Working Document, develops on the Commission’s main generic and sectorial policy, legislative initiatives and decisions adopted in application of EU competition law during 2016. For the Life Sciences sector in Read More

Reverse Patent Settlements and EU Competition Law

Mark Friend

My commentary on the EU judgment in the Lundbeck case (T-472/13), where the General Court considers the application of EU competition law to reverse patent settlements, has been published in the most recent issue of The Cambridge Law Journal. It is accessible here. Abstract: The judgment of the General Court in Case T-472/13, Lundbeck v Read More

Competition Authority reviews regulation of wholesale distribution and marketing of medicines in Spain

Patricia Carmona Botana

The Spanish National Markets and Competition Commission (CNMC) recently launched a study on the regulation of the wholesale distribution and marketing of medicinal products in Spain.  Interested parties are invited to submit their comments to the CNMC at The study is triggered by the CNCM’s acknowledgment that, despite the specific characteristics of the pharmaceutical sector Read More